Victoza 6mg/ml Solution for Injection in Pre-Filled Pen

Manufacturer
NOVO NORDISK A/S
 
Contents
Liraglutide
 
Indication
Adult w/ type 2 DM in combination w/ metformin &/or sulfonylurea, metformin & thiazolidinedione or combination therapy w/ metformin & insulin in patient w/ insufficient glycaemic control. Reduction of major adverse CV events (MACE) eg, CV death, non-fatal MI & stroke in adult w/ type 2 diabetes who have established or at high risk for CV disease.
 
Instruction
SC Initially 0.6 mg daily, may be increased to 1.2 mg after at least 1 wk. Max: 1.8 mg daily.
 
Drug interaction
Frequent monitoring of INR w/ warfarin & other coumarin derivatives.